Catalyst Pharmaceuticals, Inc.
CPRX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $53 | $52 | $57 | $56 |
| Dep. & Amort. | $9 | $9 | $9 | $9 |
| Deferred Tax | $2 | -$2 | -$2 | $3 |
| Stock-Based Comp. | $6 | $8 | $6 | $5 |
| Change in WC | -$40 | $1 | -$7 | $4 |
| Other Non-Cash | $2 | $4 | -$3 | -$7 |
| Operating Cash Flow | $32 | $71 | $60 | $71 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$0 | $0 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | -$0 | $0 | -$0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $2 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $5 | -$1 | $3 | $4 |
| Financing Cash Flow | $5 | $1 | $3 | $4 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $37 | $72 | $63 | $75 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $653 | $581 | $518 | $442 |
| End Cash | $690 | $653 | $581 | $518 |
| Free Cash Flow | $32 | $71 | $60 | $71 |